Founded in 2016, KOKEN.inc is now one of the top competitors in the HNB(heat-not-burn) market. After years of development, there is currently one heating device brand KOKEN and two heating stick brands CURELAX(nicotine-free) and CHADD. on top of that, we are working together with CNTC to make LOPATO available for the market. With our team set up in Japan, Dubai, Hong Kong, and Shenzhen, we are now in fast expansion and looking forward to building new business relationships all around the world.
To learn more about us in detail, see our official website KOKEN-Heat-Not-Burn- Leading Manufacturer (koken45.com).
KOKEN Co., Ltd
Founded in 2016, KOKEN.inc is now one of the top competitors in the HNB(heat-not-burn) market. After years of development, there is currently one heating device brand KOKEN and two heating stick brands CURELAX(nicotine-free) and CHADD. on top of that, we are working together with CNTC to make LOPATO available for the market. With our team set up in Japan, Dubai, Hong Kong, and Shenzhen, we are now in fast expansion and looking forward to building new business relationships all around the world.
To learn more about us in detail, see our official website KOKEN-Heat-Not-Burn- Leading Manufacturer (koken45.com).
Thermo Fisher Scientific (China) Co., Ltd.
Thermo Fisher Technology is a world leader in the field of scientific services, with annual sales exceeding US$30 billion. The company ’s mission is to help customers make the world healthier, cleaner and safer. Help customers accelerate research in the field of life sciences, solve complex problems and challenges encountered in the field of analysis, promote the development of medical diagnosis and treatment, and improve laboratory productivity. More than 80,000 Thermo Fisher employees around the world will provide customers with advanced innovative technologies, convenient procurement solutions and multi-faceted services through a series of industry-leading brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. Thermo Fisher Technology China In 1982, Thermo Fisher set up its first sales office in China, with its headquarters in Shanghai in China, and has established branches in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi'an, Nanjing, Wuhan, Jinan, Dongguan and other places. . The products mainly include analytical instruments, laboratory equipment, reagents, consumables and software, etc., provide comprehensive laboratory solutions to serve customers from all walks of life. In order to meet the needs of the Chinese market, the current eight factories are operated in Shanghai, Beijing, Suzhou and Guangzhou respectively. 6 application development centers and demonstration laboratories have been established nationwide to bring world-leading technologies and products to Chinese customers, and provide many services such as application development and training; China Innovation Centers located in Shanghai and Suzhou have more than 100 Professional researchers and engineers and more than 100 patents. The Innovation Center focuses on product research and development in vertical markets, combining the needs of the Chinese market and advanced technologies at home and abroad, and develops technologies and products suitable for Chinese users.
Thermo Fisher Scientific (China) Co., Ltd.
Thermo Fisher Technology is a world leader in the field of scientific services, with annual sales exceeding US$30 billion. The company ’s mission is to help customers make the world healthier, cleaner and safer. Help customers accelerate research in the field of life sciences, solve complex problems and challenges encountered in the field of analysis, promote the development of medical diagnosis and treatment, and improve laboratory productivity. More than 80,000 Thermo Fisher employees around the world will provide customers with advanced innovative technologies, convenient procurement solutions and multi-faceted services through a series of industry-leading brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. Thermo Fisher Technology China In 1982, Thermo Fisher set up its first sales office in China, with its headquarters in Shanghai in China, and has established branches in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi'an, Nanjing, Wuhan, Jinan, Dongguan and other places. . The products mainly include analytical instruments, laboratory equipment, reagents, consumables and software, etc., provide comprehensive laboratory solutions to serve customers from all walks of life. In order to meet the needs of the Chinese market, the current eight factories are operated in Shanghai, Beijing, Suzhou and Guangzhou respectively. 6 application development centers and demonstration laboratories have been established nationwide to bring world-leading technologies and products to Chinese customers, and provide many services such as application development and training; China Innovation Centers located in Shanghai and Suzhou have more than 100 Professional researchers and engineers and more than 100 patents. The Innovation Center focuses on product research and development in vertical markets, combining the needs of the Chinese market and advanced technologies at home and abroad, and develops technologies and products suitable for Chinese users.
Aika (Guangzhou) Instrument & Equipment Co., Ltd.
IKA Works GmbH & Co. is headquartered in Stauffen, Germany and has a history of 100 years. Founded in 1910, IKA was originally a supplier of equipment for pharmaceutical factories and hospitals. In 1942, IKA moved from the bombed city of Cologne to Stauffen, and then quickly developed into a world-leading enterprise specializing in laboratory technology research, dispersers, mixers and kneaders. Today, IKA has 8 branches in 4 continents and has more than 800 employees. IKA (Guangzhou) Instrument Equipment Co., Ltd. (hereinafter referred to as IKA) is a wholly-owned subsidiary established by the German IKA Group in China. IKA has nearly 900 employees in eight divisions on four continents around the world, and we are proud to have clients like BASF, Byer and Procter & Gamble. There is no doubt that we are the leader in today's market and a brilliant example of the successful development of a group enterprise. As our new slogan says: Designed to work perfectly. IKA has been designing and developing high-quality laboratory instruments, calorimetry analyzers and industrial hybrid dispersion equipment. IKA industrial equipment provides high-quality solutions in the fields of mixing, dispersion, homogenization, suspension, emulsification, wet grinding, powder and liquid mixing, and the fineness of the processing materials can reach the micro-nano level. It can be widely used in pharmaceutical, daily chemical, food, chemical and other industries.
Aika (Guangzhou) Instrument & Equipment Co., Ltd.
IKA Works GmbH & Co. is headquartered in Stauffen, Germany and has a history of 100 years. Founded in 1910, IKA was originally a supplier of equipment for pharmaceutical factories and hospitals. In 1942, IKA moved from the bombed city of Cologne to Stauffen, and then quickly developed into a world-leading enterprise specializing in laboratory technology research, dispersers, mixers and kneaders. Today, IKA has 8 branches in 4 continents and has more than 800 employees. IKA (Guangzhou) Instrument Equipment Co., Ltd. (hereinafter referred to as IKA) is a wholly-owned subsidiary established by the German IKA Group in China. IKA has nearly 900 employees in eight divisions on four continents around the world, and we are proud to have clients like BASF, Byer and Procter & Gamble. There is no doubt that we are the leader in today's market and a brilliant example of the successful development of a group enterprise. As our new slogan says: Designed to work perfectly. IKA has been designing and developing high-quality laboratory instruments, calorimetry analyzers and industrial hybrid dispersion equipment. IKA industrial equipment provides high-quality solutions in the fields of mixing, dispersion, homogenization, suspension, emulsification, wet grinding, powder and liquid mixing, and the fineness of the processing materials can reach the micro-nano level. It can be widely used in pharmaceutical, daily chemical, food, chemical and other industries.
Chemtarget Technologies Co., Ltd.
Chemtarget Technologies Co., Ltd., led by the doctor's team, Positioned as a technology company that develops new products and incubates projects and Specializes in fine chemical,Benzocyclobutene derivatives,Furan series,Square acid series,Pharmaceutical intermediate,Organic synthesis intermediates,Organic chemical raw materials products,which is located in Mianyang city, Sichuan province, the only science and technology city in China, and is the National high-tech enterprise.
Chemtarget Technologies Co., Ltd.
Chemtarget Technologies Co., Ltd., led by the doctor's team, Positioned as a technology company that develops new products and incubates projects and Specializes in fine chemical,Benzocyclobutene derivatives,Furan series,Square acid series,Pharmaceutical intermediate,Organic synthesis intermediates,Organic chemical raw materials products,which is located in Mianyang city, Sichuan province, the only science and technology city in China, and is the National high-tech enterprise.
Sartorius Scientific Instruments (Beijing) Co., Ltd.
In 1870, Florenz Sartorius founded the company Sartorius, headquartered in Göttingen, Germany. Today, the company Sartorius has taken a leading position in the fields of mechanical electronics, biotechnology and environmental technology. For more than 150 years, Sedolis has been constantly innovating and improving weighing technology and has always been at the forefront of the development of weighing technology. Sedolis' products are spread all over the world and have gained a high reputation. From Madame Curie's laboratory to NASA, from the benchmark balance of the National Institute of Metrics to the balance of the International Olympic Chemistry Competition of Peking University... all embodies Sedolis' contribution to high-tech development. Today, many diseases are still incurable. Hundreds of millions of people do not have access to economical and safe medicines. Sedolis’ biopharmaceutical customers are working to develop new drugs to improve people’s lives. To do this, they need strong partners to help them succeed. The Sedolis Group is an internationally leading partner in the biopharmaceutical industry and research field. From creativity to production, it has been helping biotechnologists and engineers around the world develop and develop drugs, so that more people can get better drugs. For the biopharmaceuticals, chemicals, food and beverage industries and academic fields, Sedolis is confident that it can meet the growing quality, efficiency, accuracy, compliance and production through instrumentation, intuitive software, internship training and complete services. demand. Rapidly start and simplify workflows with product and platform solution experiences to fully meet your laboratory and bioprocess application needs. From consumables and laboratory water purification systems to industry-leading weighing technology, Sedolis' advanced solutions also include fluid management, fermentation, and laboratory filtration.
Sartorius Scientific Instruments (Beijing) Co., Ltd.
In 1870, Florenz Sartorius founded the company Sartorius, headquartered in Göttingen, Germany. Today, the company Sartorius has taken a leading position in the fields of mechanical electronics, biotechnology and environmental technology. For more than 150 years, Sedolis has been constantly innovating and improving weighing technology and has always been at the forefront of the development of weighing technology. Sedolis' products are spread all over the world and have gained a high reputation. From Madame Curie's laboratory to NASA, from the benchmark balance of the National Institute of Metrics to the balance of the International Olympic Chemistry Competition of Peking University... all embodies Sedolis' contribution to high-tech development. Today, many diseases are still incurable. Hundreds of millions of people do not have access to economical and safe medicines. Sedolis’ biopharmaceutical customers are working to develop new drugs to improve people’s lives. To do this, they need strong partners to help them succeed. The Sedolis Group is an internationally leading partner in the biopharmaceutical industry and research field. From creativity to production, it has been helping biotechnologists and engineers around the world develop and develop drugs, so that more people can get better drugs. For the biopharmaceuticals, chemicals, food and beverage industries and academic fields, Sedolis is confident that it can meet the growing quality, efficiency, accuracy, compliance and production through instrumentation, intuitive software, internship training and complete services. demand. Rapidly start and simplify workflows with product and platform solution experiences to fully meet your laboratory and bioprocess application needs. From consumables and laboratory water purification systems to industry-leading weighing technology, Sedolis' advanced solutions also include fluid management, fermentation, and laboratory filtration.
Wuxi NEST Biotechnology Co.,Ltd
Found in 2009,Wuxi NEST Biotechnology is a worldwide manufacturer of plastic laboratory products. State-of-the-art manufacturing equipment is used on an expansive manufacturing site based in Wuxi, China. Decades of plastic-injection molding experience allows us to maintain the highest quality and performance standards expected by the hospitals, research institutions and indusrial/clinical laboraories that we serve, NEST is your best choice for laboratory consumables.
NEST has launched over 200 plastic consumable products for cell culture, molecular bislogy, immunoassays, liquid handling and storage. With stricty controlled ISO 8 grade clean rooms, exacting manufacturing standards and rigid QA procedures, the NEST brand enjoys an excellent reputation nationwide and abroad. NEST products have been exported to North America, Europe, Japan, Korea, India and other countries. NEST is committed to innovation. We continue to research and develop new platic consumables suitable for life sciences research so that we can provide more cost-effective solutions and cutting-edge laboratory consumables for our end-users. NEST has continually positioned itself as a brand for high end laboratory consumables.
NEST boasts of a high power laminar flow clean room meeting the ISO 8 grade with a floor space of 2,000 square meters. These facilities are equipped with a central feeding system, high precision injection machinery from Japan, robot arms with automatic conveyers, hot runner molds, and vacuum plasma and corona treatment machines from Belgium, Germany and USA. Inner room moisture content and temperature are adjustable. In 2013, NEST installed a Rhodotron TT 200 from Belgium IBA, a world leader in the E-Beam sterilization industry. NEST completes a full process chain from the sourcing of the raw materials to the in-house sterilization of the final products ready for delivery to clients. NEST`s manufacturing site has been certified with an ISO 9001:2008 management system. Our sterilization procedures meet the ISO 11137:2006 and ISO 13485 standards.
Wuxi NEST Biotechnology Co.,Ltd
Found in 2009,Wuxi NEST Biotechnology is a worldwide manufacturer of plastic laboratory products. State-of-the-art manufacturing equipment is used on an expansive manufacturing site based in Wuxi, China. Decades of plastic-injection molding experience allows us to maintain the highest quality and performance standards expected by the hospitals, research institutions and indusrial/clinical laboraories that we serve, NEST is your best choice for laboratory consumables.
NEST has launched over 200 plastic consumable products for cell culture, molecular bislogy, immunoassays, liquid handling and storage. With stricty controlled ISO 8 grade clean rooms, exacting manufacturing standards and rigid QA procedures, the NEST brand enjoys an excellent reputation nationwide and abroad. NEST products have been exported to North America, Europe, Japan, Korea, India and other countries. NEST is committed to innovation. We continue to research and develop new platic consumables suitable for life sciences research so that we can provide more cost-effective solutions and cutting-edge laboratory consumables for our end-users. NEST has continually positioned itself as a brand for high end laboratory consumables.
NEST boasts of a high power laminar flow clean room meeting the ISO 8 grade with a floor space of 2,000 square meters. These facilities are equipped with a central feeding system, high precision injection machinery from Japan, robot arms with automatic conveyers, hot runner molds, and vacuum plasma and corona treatment machines from Belgium, Germany and USA. Inner room moisture content and temperature are adjustable. In 2013, NEST installed a Rhodotron TT 200 from Belgium IBA, a world leader in the E-Beam sterilization industry. NEST completes a full process chain from the sourcing of the raw materials to the in-house sterilization of the final products ready for delivery to clients. NEST`s manufacturing site has been certified with an ISO 9001:2008 management system. Our sterilization procedures meet the ISO 11137:2006 and ISO 13485 standards.
Merck Investments (China) Co., Ltd.
Merck KGaA was founded in 1668 and has a history of about 350 years. It is headquartered in Darmstadt, Germany. It is mainly committed to innovative pharmaceuticals, life sciences and cutting-edge functional material technologies, and Technology is the driving force to create value for patients and customers. Merck began to engage in trade with China at the end of the 19th century, selling high-purity chemical reagents to China, and established a Chinese subsidiary in Shanghai in 1933. In China, Merck is mainly engaged in pharmaceutical, life sciences and chemical businesses, and provides customers with solutions from innovative prescription drugs, over-the-counter drugs to life sciences, effective pigments and chemicals for industrial purposes. Merck's business is mainly divided into four major branches: Merck Serono business branch, consumer health care business branch, Merck Millipo business branch, and functional materials business branch. Merck is a partner of China. Merck has a history of development in China for more than 80 years. China is an important strategic market for all Merck's business areas (including high-performance materials, life sciences and medical health); Merck has 3,200 employees in China (including Hong Kong and Macau); in Beijing, Shanghai, Hong Kong, Wuxi, Suzhou and Nantong has 20 corporate entities. Merck has many important investments in China. Recently, Merck's pharmaceutical, health and life sciences business in Nantong and its high-performance materials business in Shanghai have invested 170 million euros, 80 million euros and 44 million euros respectively. In addition, Merck has also set up a global biopharmaceutical R&D center in Beijing, a display material R&D center and a life science laboratory in Shanghai, and a lithographic material R&D center in Suzhou. China has become an important source of innovation for Merck.
Merck Investments (China) Co., Ltd.
Merck KGaA was founded in 1668 and has a history of about 350 years. It is headquartered in Darmstadt, Germany. It is mainly committed to innovative pharmaceuticals, life sciences and cutting-edge functional material technologies, and Technology is the driving force to create value for patients and customers. Merck began to engage in trade with China at the end of the 19th century, selling high-purity chemical reagents to China, and established a Chinese subsidiary in Shanghai in 1933. In China, Merck is mainly engaged in pharmaceutical, life sciences and chemical businesses, and provides customers with solutions from innovative prescription drugs, over-the-counter drugs to life sciences, effective pigments and chemicals for industrial purposes. Merck's business is mainly divided into four major branches: Merck Serono business branch, consumer health care business branch, Merck Millipo business branch, and functional materials business branch. Merck is a partner of China. Merck has a history of development in China for more than 80 years. China is an important strategic market for all Merck's business areas (including high-performance materials, life sciences and medical health); Merck has 3,200 employees in China (including Hong Kong and Macau); in Beijing, Shanghai, Hong Kong, Wuxi, Suzhou and Nantong has 20 corporate entities. Merck has many important investments in China. Recently, Merck's pharmaceutical, health and life sciences business in Nantong and its high-performance materials business in Shanghai have invested 170 million euros, 80 million euros and 44 million euros respectively. In addition, Merck has also set up a global biopharmaceutical R&D center in Beijing, a display material R&D center and a life science laboratory in Shanghai, and a lithographic material R&D center in Suzhou. China has become an important source of innovation for Merck.
Glaser Life Sciences (Shanghai) Co., Ltd.
Cytiva is a global technology and service provider committed to promoting unseen technologies and accelerating extraordinary therapies. Cytiva's long history goes back hundreds of years ago, becoming an independently operated company under the Danaher Group in 2020, and has embarked on a new journey. From basic biological research to innovative vaccine research and development, from biomedicine to the development of new cell and gene therapies, the work of Cytiva Stufan’s clients is closely related to life. Cytiva's products and services provide strong support to customers, helping them accelerate research, reduce costs and increase efficiency, thereby benefiting patients around the world. In 2020, most monoclonal antibodies approved by the U.S. Food and Drug Administration use Cytiva's technology during their production process. Cytiva takes pride in it and will continue to develop stable and reliable solutions to help more life-saving therapies. Through replicable modern biotechnology technologies and cell and gene therapy facilities, Cytiva provides you with tools and expertise to advance research and introduce key therapies into the clinic. Cytiva serves the production process of approved and registered biomedicine (including cell and gene therapy) with a steady stream of products. Cytiva Situfan always practices the concept of sustainable development and truly meets the needs of current patients without sacrificing the interests of future generations.
Glaser Life Sciences (Shanghai) Co., Ltd.
Cytiva is a global technology and service provider committed to promoting unseen technologies and accelerating extraordinary therapies. Cytiva's long history goes back hundreds of years ago, becoming an independently operated company under the Danaher Group in 2020, and has embarked on a new journey. From basic biological research to innovative vaccine research and development, from biomedicine to the development of new cell and gene therapies, the work of Cytiva Stufan’s clients is closely related to life. Cytiva's products and services provide strong support to customers, helping them accelerate research, reduce costs and increase efficiency, thereby benefiting patients around the world. In 2020, most monoclonal antibodies approved by the U.S. Food and Drug Administration use Cytiva's technology during their production process. Cytiva takes pride in it and will continue to develop stable and reliable solutions to help more life-saving therapies. Through replicable modern biotechnology technologies and cell and gene therapy facilities, Cytiva provides you with tools and expertise to advance research and introduce key therapies into the clinic. Cytiva serves the production process of approved and registered biomedicine (including cell and gene therapy) with a steady stream of products. Cytiva Situfan always practices the concept of sustainable development and truly meets the needs of current patients without sacrificing the interests of future generations.
Moriaki (China) Investment Co., Ltd.
Morimatsu originated from Japan, based in China, and has been globally located. It has now developed into a diversified multinational company that masters core technologies in the fields of core equipment, process systems, engineering solutions and other fields and has rich project experience. Relying on its advanced manufacturing base in China, the company has opened subsidiaries in Sweden, the United States, India, Italy and other places, and relying on its global efficient professional team, it has delivered different forms of products to more than 40 countries and regions so far. and service. Headquartered in Pudong New District, Shanghai, China, Monasonic International Holdings Co., Ltd. is an advanced pressure equipment manufacturer and comprehensive pressure equipment solution supplier in China, providing traditional pressure equipment, modular pressure equipment and value-added services related to pressure equipment. Morimatsu International Holdings Co., Ltd. inherits the advanced technology inherited by Japanese controlling shareholder Morimatsu Industrial Co., Ltd., and combines the advantages of Pharmadule technology and China's production capacity. Morimatsu has a solid market position in China and is committed to becoming an advanced core pressure equipment and engineering. Provider of solutions. According to the Frost-Sullivan report, based on sales revenue in 2019, Morimatsu is China's fourth largest pressure equipment manufacturer and comprehensive pressure equipment solution supplier, and is also China's largest non-state-owned pressure equipment manufacturer and comprehensive pressure equipment manufacturer and comprehensive pressure equipment. Solution supplier.
Moriaki (China) Investment Co., Ltd.
Morimatsu originated from Japan, based in China, and has been globally located. It has now developed into a diversified multinational company that masters core technologies in the fields of core equipment, process systems, engineering solutions and other fields and has rich project experience. Relying on its advanced manufacturing base in China, the company has opened subsidiaries in Sweden, the United States, India, Italy and other places, and relying on its global efficient professional team, it has delivered different forms of products to more than 40 countries and regions so far. and service. Headquartered in Pudong New District, Shanghai, China, Monasonic International Holdings Co., Ltd. is an advanced pressure equipment manufacturer and comprehensive pressure equipment solution supplier in China, providing traditional pressure equipment, modular pressure equipment and value-added services related to pressure equipment. Morimatsu International Holdings Co., Ltd. inherits the advanced technology inherited by Japanese controlling shareholder Morimatsu Industrial Co., Ltd., and combines the advantages of Pharmadule technology and China's production capacity. Morimatsu has a solid market position in China and is committed to becoming an advanced core pressure equipment and engineering. Provider of solutions. According to the Frost-Sullivan report, based on sales revenue in 2019, Morimatsu is China's fourth largest pressure equipment manufacturer and comprehensive pressure equipment solution supplier, and is also China's largest non-state-owned pressure equipment manufacturer and comprehensive pressure equipment manufacturer and comprehensive pressure equipment. Solution supplier.
Chutian Technology Co., Ltd.
Chutian Technology Co., Ltd. was established in 2000. It is a leading enterprise in China's pharmaceutical equipment industry and one of the well-known enterprises in the world's pharmaceutical equipment industry. The main business is pharmaceutical equipment and its overall technical solutions, and it has promoted the research and development of smart pharmaceutical factories earlier. The company is a listed company in China's A-share market. It owns German ROMACO Group, Chutian Huatong, Sichuan Medical Design Research Institute, Chutian Feiyun, Chutian Yuanchuang, Chutian Microsphere, Chutian SUT, Chutian Siweikang, Chutian Huaxing, Chutian Changxing, Chutian Intelligent Robot and other wholly-owned or controlled subsidiaries have a total of more than 8,000 employees worldwide, total assets of 11 billion yuan, and an annual industrial output value of more than 7 billion yuan. The company already has two major operating headquarters in Changsha and Germany, and has three major R&D institutions: Changsha Central Technology Research Institute, European Technology Research Institute and Sichuan Medical Design Institute. It has multiple technology and innovation platforms such as national enterprise technology centers, national innovation bases, postdoctoral research workstations, academician and expert workstations. The products have been exported to nearly 60 countries and regions including Asia, Europe, South America, and international market share is increasing rapidly year by year. The company is fully committed to building the "Chutian Biomedicine and Life Sciences Industry Chain", entering the field of biomedicine polymer materials and the field of life science gene technology, and is advancing rapidly towards the goal of a trillion-dollar industrial chain. The company adheres to the core values of "being respected people, creating respected products, and running respected enterprises", promotes the spirit of "excellence because of persistence", and implements "customer-centered, striving first, and The business purpose of target responsibility and result-oriented" is to fulfill the mission of giving the world pharmaceutical industry a wing of wisdom, and strive to build Chutian into one of the leading companies in the global pharmaceutical equipment industry around 2030.
Chutian Technology Co., Ltd.
Chutian Technology Co., Ltd. was established in 2000. It is a leading enterprise in China's pharmaceutical equipment industry and one of the well-known enterprises in the world's pharmaceutical equipment industry. The main business is pharmaceutical equipment and its overall technical solutions, and it has promoted the research and development of smart pharmaceutical factories earlier. The company is a listed company in China's A-share market. It owns German ROMACO Group, Chutian Huatong, Sichuan Medical Design Research Institute, Chutian Feiyun, Chutian Yuanchuang, Chutian Microsphere, Chutian SUT, Chutian Siweikang, Chutian Huaxing, Chutian Changxing, Chutian Intelligent Robot and other wholly-owned or controlled subsidiaries have a total of more than 8,000 employees worldwide, total assets of 11 billion yuan, and an annual industrial output value of more than 7 billion yuan. The company already has two major operating headquarters in Changsha and Germany, and has three major R&D institutions: Changsha Central Technology Research Institute, European Technology Research Institute and Sichuan Medical Design Institute. It has multiple technology and innovation platforms such as national enterprise technology centers, national innovation bases, postdoctoral research workstations, academician and expert workstations. The products have been exported to nearly 60 countries and regions including Asia, Europe, South America, and international market share is increasing rapidly year by year. The company is fully committed to building the "Chutian Biomedicine and Life Sciences Industry Chain", entering the field of biomedicine polymer materials and the field of life science gene technology, and is advancing rapidly towards the goal of a trillion-dollar industrial chain. The company adheres to the core values of "being respected people, creating respected products, and running respected enterprises", promotes the spirit of "excellence because of persistence", and implements "customer-centered, striving first, and The business purpose of target responsibility and result-oriented" is to fulfill the mission of giving the world pharmaceutical industry a wing of wisdom, and strive to build Chutian into one of the leading companies in the global pharmaceutical equipment industry around 2030.
Hubei CuiRan Biotechnology Co., Ltd
Hubei CuiRan Biotechnology Co., Ltd. is a high-tech enterprise that integrates research and development, production, and sales. It mainly engages in the production, customization, and production process development of high-purity Chinese medicine chemical components, Chinese medicine reference materials, high-quality extracts, natural product intermediates, and drug impurities.
Focusing on the development and application of natural products in major health fields such as medicine, food, and daily chemicals, as well as the basic research of traditional Chinese medicine substances and the internationalization of traditional Chinese medicine quality standards; Serving global research institutions, universities, and various end customers.
The company currently has over 2200 types of natural compounds and corresponding compound libraries for you to choose from, providing various specifications of individual packaging and customized series of compound group packaging (such as standard 96 well plate and 384 well plate packaging). CuiRan has independent laboratories and production workshops, which can provide you with cost-effective products and customized product services, scaling up production to provide demand from milligrams to grams.
Hubei CuiRan Biotechnology Co., Ltd
Hubei CuiRan Biotechnology Co., Ltd. is a high-tech enterprise that integrates research and development, production, and sales. It mainly engages in the production, customization, and production process development of high-purity Chinese medicine chemical components, Chinese medicine reference materials, high-quality extracts, natural product intermediates, and drug impurities.
Focusing on the development and application of natural products in major health fields such as medicine, food, and daily chemicals, as well as the basic research of traditional Chinese medicine substances and the internationalization of traditional Chinese medicine quality standards; Serving global research institutions, universities, and various end customers.
The company currently has over 2200 types of natural compounds and corresponding compound libraries for you to choose from, providing various specifications of individual packaging and customized series of compound group packaging (such as standard 96 well plate and 384 well plate packaging). CuiRan has independent laboratories and production workshops, which can provide you with cost-effective products and customized product services, scaling up production to provide demand from milligrams to grams.
Tianxinhe (Suzhou) Biotechnology Co., Ltd.
Zhongsheng Tianxinhe (Wuxi) Biotechnology Co., Ltd., a service provider and supplier of biopharmaceutical process technology and solutions, focuses on improving the independent and controllable capabilities of China's upstream raw materials and equipment, and accelerating the development of the biopharmaceutical industry. Tianxinhe focuses on the research and production of personalized cell culture media, bioreactor process design and manufacturing, large-scale animal cell culture process technology research, and development and transfer of biological process technology. Based on this, it has constructed the biopharmaceutical process technology technology. Development platform. Tianxinhe (Suzhou) Biotechnology Co., Ltd. is a wholly-owned subsidiary of Zhongsheng Tianxinhe (Wuxi) Biotechnology Co., Ltd. It covers a total area of 8,000 square meters in Wujiang, Suzhou, and has built a 5,000 square meters of cell culture medium that meets GMP requirements. Workshop, bioreactor production workshop and R&D laboratory. The company has passed the ISO9001:2015 quality management system and ISO14001:2015 environmental management system certification. The annual output of cell culture medium reaches 150 tons, and the annual output of bioreactors is more than 50 sets, which can meet the dynamic needs of the development of the biopharmaceutical industry such as antibodies and vaccines. .
Tianxinhe (Suzhou) Biotechnology Co., Ltd.
Zhongsheng Tianxinhe (Wuxi) Biotechnology Co., Ltd., a service provider and supplier of biopharmaceutical process technology and solutions, focuses on improving the independent and controllable capabilities of China's upstream raw materials and equipment, and accelerating the development of the biopharmaceutical industry. Tianxinhe focuses on the research and production of personalized cell culture media, bioreactor process design and manufacturing, large-scale animal cell culture process technology research, and development and transfer of biological process technology. Based on this, it has constructed the biopharmaceutical process technology technology. Development platform. Tianxinhe (Suzhou) Biotechnology Co., Ltd. is a wholly-owned subsidiary of Zhongsheng Tianxinhe (Wuxi) Biotechnology Co., Ltd. It covers a total area of 8,000 square meters in Wujiang, Suzhou, and has built a 5,000 square meters of cell culture medium that meets GMP requirements. Workshop, bioreactor production workshop and R&D laboratory. The company has passed the ISO9001:2015 quality management system and ISO14001:2015 environmental management system certification. The annual output of cell culture medium reaches 150 tons, and the annual output of bioreactors is more than 50 sets, which can meet the dynamic needs of the development of the biopharmaceutical industry such as antibodies and vaccines. .
Eppendorf (Shanghai) International Trading Co., Ltd.
Eppendorf is a cutting-edge life sciences company focusing on the research and development and sale of lab instruments, consumables and services for liquid processing, sample processing and cell processing. Main products include pipettes, automatic pipetting systems, dispensers, centrifuges, mixing instruments, spectrophotometers and DNA amplification instruments, as well as ultra-low temperature refrigerators, fermentation tanks, bioreactors, CO2 incubators, and bioshaking beds and cell microscopy operating systems, consumables include high-performance high-quality products such as pipettes, centrifuge tubes, PCR plates, microplates and disposable bioreactor tanks. Eppendorf's products are widely used in scientific research and commercial R&D laboratories, such as pharmaceutical and biotechnology, chemistry and food industries. In addition, the company's products are also widely used by clinical and environmental analysis laboratories, forensics and industrial users in process analysis, production and quality testing. Founded in 1945, Eppendorf is headquartered in Hamburg, Germany and currently employs about 4,500 people worldwide. The company has subsidiaries in 28 countries and has distributors in relevant and important market areas around the world.
Eppendorf (Shanghai) International Trading Co., Ltd.
Eppendorf is a cutting-edge life sciences company focusing on the research and development and sale of lab instruments, consumables and services for liquid processing, sample processing and cell processing. Main products include pipettes, automatic pipetting systems, dispensers, centrifuges, mixing instruments, spectrophotometers and DNA amplification instruments, as well as ultra-low temperature refrigerators, fermentation tanks, bioreactors, CO2 incubators, and bioshaking beds and cell microscopy operating systems, consumables include high-performance high-quality products such as pipettes, centrifuge tubes, PCR plates, microplates and disposable bioreactor tanks. Eppendorf's products are widely used in scientific research and commercial R&D laboratories, such as pharmaceutical and biotechnology, chemistry and food industries. In addition, the company's products are also widely used by clinical and environmental analysis laboratories, forensics and industrial users in process analysis, production and quality testing. Founded in 1945, Eppendorf is headquartered in Hamburg, Germany and currently employs about 4,500 people worldwide. The company has subsidiaries in 28 countries and has distributors in relevant and important market areas around the world.
Lanyao Water Treatment Co.,Ltd.
LANYAO WATERTREATMENT CO, LTD, founded in the early 1990s, is currently located in the chemical area of Yixing Industrial Zone, Jiangsu Province, with 20000 square metersfactory areaIt is a professional enterprise that integrates research, production, sales, and technical after-sales servic e of water collection treatment agents. Lanyao has a registered capital of 30 million RMB and an annual profit and tax of over 28 million RMB. The company currently has more than 80 employees and has a complete set of production management processes and quality supervision systems. It is supported by advanced testing equipment and mature process systems, which have enabled the company to win praise and trust from numerous domestic and foreign users with high-quality products and services. Our company's organizational structure consists of five departments and one office: Marketing Department, Technology Research and Development Department, Business Management Department, Engineering Business Department, Financial Settlement Department, and Comprehensive Office. The Engineering Business Department has Nantong Branch, Suzhou Branch, Jiangxi Branch, and Hong Kong Branch. Our company has passed ISO9001 quality system certification , ISO14001 environmental system certification, occupational health and safety management system certification, CE, ROHS, SGS and other international certifications since 2012. The business of industrial water medicament and drinking water medicament is widespread, covering Jiangsu, Zhejiang, Anhui, Shanghai, Jiangxi, Fujian, Northeast, Xizang and other places in China, and Vietnam, Thailand, Malaysia, Indonesia, Russia, Europe and other countries overseas.
After more than 30 years of market competition and historical accumulation, our company has a unique and comprehensive pre-sales and after-sales service system, providing regular training and technical guidance to customers. In the continuous competition, we have formed the corporate philosophy of "seeking truth and pragmatism, striving for innovation, cooperating and advancing together, and sharing value".
Lanyao Water Treatment Co.,Ltd.
LANYAO WATERTREATMENT CO, LTD, founded in the early 1990s, is currently located in the chemical area of Yixing Industrial Zone, Jiangsu Province, with 20000 square metersfactory areaIt is a professional enterprise that integrates research, production, sales, and technical after-sales servic e of water collection treatment agents. Lanyao has a registered capital of 30 million RMB and an annual profit and tax of over 28 million RMB. The company currently has more than 80 employees and has a complete set of production management processes and quality supervision systems. It is supported by advanced testing equipment and mature process systems, which have enabled the company to win praise and trust from numerous domestic and foreign users with high-quality products and services. Our company's organizational structure consists of five departments and one office: Marketing Department, Technology Research and Development Department, Business Management Department, Engineering Business Department, Financial Settlement Department, and Comprehensive Office. The Engineering Business Department has Nantong Branch, Suzhou Branch, Jiangxi Branch, and Hong Kong Branch. Our company has passed ISO9001 quality system certification , ISO14001 environmental system certification, occupational health and safety management system certification, CE, ROHS, SGS and other international certifications since 2012. The business of industrial water medicament and drinking water medicament is widespread, covering Jiangsu, Zhejiang, Anhui, Shanghai, Jiangxi, Fujian, Northeast, Xizang and other places in China, and Vietnam, Thailand, Malaysia, Indonesia, Russia, Europe and other countries overseas.
After more than 30 years of market competition and historical accumulation, our company has a unique and comprehensive pre-sales and after-sales service system, providing regular training and technical guidance to customers. In the continuous competition, we have formed the corporate philosophy of "seeking truth and pragmatism, striving for innovation, cooperating and advancing together, and sharing value".
Since its inception in 1974, ABEC has been a leader in providing overall solutions and services for the production of the biopharmaceutical industry. Most of the global pharmaceutical companies and biotech companies are ABEC customers. Many mainstream drugs are produced by ABEC's equipment designed, manufactured, installed and served. The many characteristics of rich experience, complete internal strength, customized customer, flexible methods, and trustworthiness have created the unique value of ABEC in the industry. Whether it is expanding production capacity or upgrading existing equipment, ABEC's turnkey solutions and support can ensure production capacity while reducing total costs and shortening time to market. ABEC provides the industry's largest global biopharmaceutical equipment manufacturing capacity. The total area of the ABEC equipment manufacturing plant is close to 32,000m² and two ISO-7 clean rooms, with strong equipment construction capabilities and complex factory acceptance testing (FAT) large system configuration. ABEC is committed to supporting the growing biopharmaceutical manufacturing industry and continuously reinvest and expanding its capacity and capacity. Founded in the early days of biotechnology, ABEC has been an innovative leader in biotechnology engineering and equipment design. Before the 1990s, ABEC made a lot of improvements in system design, material and surface treatment, CIP/SIP integration, sterile agitator seal, sanitary component design, mixing and mass transfer, document preparation and automation. Since then, ABEC’s leadership in innovation has continued with further development of products, services and global infrastructure, with strategic investments reshaping ABEC’s ability to deliver holistic bioprocess solutions and services worldwide. For more than 40 years, ABEC has been at the forefront of innovation in biopharmaceutical production technology, providing key equipment and services to help customers reach higher levels of productivity. Pharmaceutical companies around the world use ABEC to help deliver “life-changing” drugs. In everything ABEC does, it is committed to providing high-quality products and services to enable customers to succeed, which is also the value of ABEC.
ABEC
Since its inception in 1974, ABEC has been a leader in providing overall solutions and services for the production of the biopharmaceutical industry. Most of the global pharmaceutical companies and biotech companies are ABEC customers. Many mainstream drugs are produced by ABEC's equipment designed, manufactured, installed and served. The many characteristics of rich experience, complete internal strength, customized customer, flexible methods, and trustworthiness have created the unique value of ABEC in the industry. Whether it is expanding production capacity or upgrading existing equipment, ABEC's turnkey solutions and support can ensure production capacity while reducing total costs and shortening time to market. ABEC provides the industry's largest global biopharmaceutical equipment manufacturing capacity. The total area of the ABEC equipment manufacturing plant is close to 32,000m² and two ISO-7 clean rooms, with strong equipment construction capabilities and complex factory acceptance testing (FAT) large system configuration. ABEC is committed to supporting the growing biopharmaceutical manufacturing industry and continuously reinvest and expanding its capacity and capacity. Founded in the early days of biotechnology, ABEC has been an innovative leader in biotechnology engineering and equipment design. Before the 1990s, ABEC made a lot of improvements in system design, material and surface treatment, CIP/SIP integration, sterile agitator seal, sanitary component design, mixing and mass transfer, document preparation and automation. Since then, ABEC’s leadership in innovation has continued with further development of products, services and global infrastructure, with strategic investments reshaping ABEC’s ability to deliver holistic bioprocess solutions and services worldwide. For more than 40 years, ABEC has been at the forefront of innovation in biopharmaceutical production technology, providing key equipment and services to help customers reach higher levels of productivity. Pharmaceutical companies around the world use ABEC to help deliver “life-changing” drugs. In everything ABEC does, it is committed to providing high-quality products and services to enable customers to succeed, which is also the value of ABEC.
Tofflon Science & Technology Group Co., Ltd.
Dongfulong (stock code 300171) was established in 1993 and was listed on the GEM in 2011. It is headquartered in Shanghai. It is an overall solution service provider that provides process services and consumables, core equipment and engineering to global pharmaceutical companies . Dongfulong Adhering to the core values of "Heavenly Rewards", adhering to the mission of "professional technology serves biomedicine", and constantly moving forward with the "systematized, internationalized, digital and intelligent development path. Dongfulong has four core business units: Biotechnology, Preparation Equipment Department, Pharmaceutical Engineering Department, and Food Engineering Department. So far, there are 26 domestic holding subsidiaries including Dongfulong Life Technology and Dongfulong Dehui. , 13 overseas holding subsidiaries, 8 basic manufacturing sites at home and abroad, with three global R&D centers in China, the United States and Germany. Dongfulong continues to strengthen research on drug manufacturing science and pharmaceutical machinery scientific manufacturing, and is committed to creating the next generation The drug and platform are built to provide professional solutions for customers in R&D, pilot and commercial production, and help rapid drug development and large-scale commercial production.
Tofflon Science & Technology Group Co., Ltd.
Dongfulong (stock code 300171) was established in 1993 and was listed on the GEM in 2011. It is headquartered in Shanghai. It is an overall solution service provider that provides process services and consumables, core equipment and engineering to global pharmaceutical companies . Dongfulong Adhering to the core values of "Heavenly Rewards", adhering to the mission of "professional technology serves biomedicine", and constantly moving forward with the "systematized, internationalized, digital and intelligent development path. Dongfulong has four core business units: Biotechnology, Preparation Equipment Department, Pharmaceutical Engineering Department, and Food Engineering Department. So far, there are 26 domestic holding subsidiaries including Dongfulong Life Technology and Dongfulong Dehui. , 13 overseas holding subsidiaries, 8 basic manufacturing sites at home and abroad, with three global R&D centers in China, the United States and Germany. Dongfulong continues to strengthen research on drug manufacturing science and pharmaceutical machinery scientific manufacturing, and is committed to creating the next generation The drug and platform are built to provide professional solutions for customers in R&D, pilot and commercial production, and help rapid drug development and large-scale commercial production.
Shanghai Dunning Biotechnology Co., Ltd.
Shanghai Duoning Biotechnology Co., Ltd. was established in 2005. It is deeply engaged in the field of life sciences and is committed to providing one-stop solutions for biopharmaceutical customers, focusing on process equipment, consumables and services from development to commercial production of biotechnology. , provide related products and services for laboratory research. Since the establishment of Shanghai Duoning Biotechnology Company in 2005, after nearly 15 years of continuous research and development and accumulation, Duoning Biotechnology has established an advanced culture medium development platform. With the development of the biopharmaceutical industry, in response to customers' needs for personalized cell culture media, Duaning Bio has a rich medium formula library platform with independent property rights, and can use advanced medium development concepts and technical advantages to Develop personalized culture media suitable for specific needs for customers to meet the needs of different cell lines, different expression products and different production processes, helping customers improve production and improve product quality. Duaning is customized, formulated and produced according to customer requirements, and can also provide mature formula solutions to meet customer needs. Based on the principle of helping customers optimize cell culture processes, reduce production costs, and win-win cooperation, the company customized high-quality and personalized animal cell culture media according to customer needs.
Shanghai Dunning Biotechnology Co., Ltd.
Shanghai Duoning Biotechnology Co., Ltd. was established in 2005. It is deeply engaged in the field of life sciences and is committed to providing one-stop solutions for biopharmaceutical customers, focusing on process equipment, consumables and services from development to commercial production of biotechnology. , provide related products and services for laboratory research. Since the establishment of Shanghai Duoning Biotechnology Company in 2005, after nearly 15 years of continuous research and development and accumulation, Duoning Biotechnology has established an advanced culture medium development platform. With the development of the biopharmaceutical industry, in response to customers' needs for personalized cell culture media, Duaning Bio has a rich medium formula library platform with independent property rights, and can use advanced medium development concepts and technical advantages to Develop personalized culture media suitable for specific needs for customers to meet the needs of different cell lines, different expression products and different production processes, helping customers improve production and improve product quality. Duaning is customized, formulated and produced according to customer requirements, and can also provide mature formula solutions to meet customer needs. Based on the principle of helping customers optimize cell culture processes, reduce production costs, and win-win cooperation, the company customized high-quality and personalized animal cell culture media according to customer needs.
Dongying Kexing International Trade Co., Ltd
Shandong Kexing Chemical Co., Ltd. is specialized in the manufacture of plasticizers. Boasting leading technology and top-notch technicians, the company is located in Dawang Economic Development Zone in Guangrao County in Dongying, Shandong, China, and is close to Dong-Qing Expressway, enjoying good location. Currently, the company has 58 employees including 13 senior experts. Upholding the tenet of "Credit Based, Customer Foremost, Market Oriented", we have been keeping optimizing products structure, innovating technologies and expanding marketing strength, and have been widely recognized among users and industry partners. Main products include DOP, DBP, DIBP, DOA, DOS, DIBA, tributyl citrate etc. We have established nation-wide marketing network, and exported products to South Korea, Japan and the Southeast Asia.
We boast sound Q. C. System and top spectrograph series inspection devices, and always enjoy a product 100% percent of pass. And the company has even been honored as "AAA-grade Star Enterprise", "Honest Business Company", to name just a few.
Facing both the challenges and opportunities in the new century, we sincerely hope to cooperate with all friends for common development!
Dongying Kexing International Trade Co., Ltd
Shandong Kexing Chemical Co., Ltd. is specialized in the manufacture of plasticizers. Boasting leading technology and top-notch technicians, the company is located in Dawang Economic Development Zone in Guangrao County in Dongying, Shandong, China, and is close to Dong-Qing Expressway, enjoying good location. Currently, the company has 58 employees including 13 senior experts. Upholding the tenet of "Credit Based, Customer Foremost, Market Oriented", we have been keeping optimizing products structure, innovating technologies and expanding marketing strength, and have been widely recognized among users and industry partners. Main products include DOP, DBP, DIBP, DOA, DOS, DIBA, tributyl citrate etc. We have established nation-wide marketing network, and exported products to South Korea, Japan and the Southeast Asia.
We boast sound Q. C. System and top spectrograph series inspection devices, and always enjoy a product 100% percent of pass. And the company has even been honored as "AAA-grade Star Enterprise", "Honest Business Company", to name just a few.
Facing both the challenges and opportunities in the new century, we sincerely hope to cooperate with all friends for common development!
Corning (Shanghai) Management Co., Ltd.
Corning is one of the world's advanced innovators in the field of materials science and has been committed to life-changing innovation. Corning combines its profound expertise in glass science, ceramic science and optical physics with deep production and engineering capabilities to create numerous products that disrupt industries and improve people's lives. Corning has been successful by continuously investing in R&D and engineering to combine materials with process innovation in a unique way and establishing close trust relationships with global industry customers. Corning has a diversified business scope and good collaboration capabilities to meet the ever-evolving market needs and help customers capture more opportunities in dynamic markets. Today, Corning's products cover optical communications, mobile consumer electronics, display technology, automotive applications and life sciences. Corning's industry's advanced products include damage-resistant cover glass for mobile devices; precision glass for advanced displays; fiber optic, wireless communication technology and connector solutions for modern communication networks; trusted to promote drug development and transportation products; and air purification technology for automobiles and trucks.
Corning (Shanghai) Management Co., Ltd.
Corning is one of the world's advanced innovators in the field of materials science and has been committed to life-changing innovation. Corning combines its profound expertise in glass science, ceramic science and optical physics with deep production and engineering capabilities to create numerous products that disrupt industries and improve people's lives. Corning has been successful by continuously investing in R&D and engineering to combine materials with process innovation in a unique way and establishing close trust relationships with global industry customers. Corning has a diversified business scope and good collaboration capabilities to meet the ever-evolving market needs and help customers capture more opportunities in dynamic markets. Today, Corning's products cover optical communications, mobile consumer electronics, display technology, automotive applications and life sciences. Corning's industry's advanced products include damage-resistant cover glass for mobile devices; precision glass for advanced displays; fiber optic, wireless communication technology and connector solutions for modern communication networks; trusted to promote drug development and transportation products; and air purification technology for automobiles and trucks.
Shanghai Sinoexpo Informa Markets
PharmaSources.com, as a vertical e-commerce online marketplace serving the pharmaceutical industry, is now upgraded from CPhI.CN (www.en-cphi.cn) after its 10 years` developing in the industry. It is dedicated to providing information of high-quality products and suppliers for global customers and delivering services to over 90,000 active members across 211 countries and regions, featuring over 1,600,000 products in 30 major categories spanning the entire pharma supply chain. Our mission is to connect global buyers with quality suppliers and facilitate easy trade of the pharmaceutical industry.
Shanghai Sinoexpo Informa Markets
PharmaSources.com, as a vertical e-commerce online marketplace serving the pharmaceutical industry, is now upgraded from CPhI.CN (www.en-cphi.cn) after its 10 years` developing in the industry. It is dedicated to providing information of high-quality products and suppliers for global customers and delivering services to over 90,000 active members across 211 countries and regions, featuring over 1,600,000 products in 30 major categories spanning the entire pharma supply chain. Our mission is to connect global buyers with quality suppliers and facilitate easy trade of the pharmaceutical industry.
